https://orcid.org/0000-0002-3187-5673
References
- Bazak R, Houri M, El Achy S, Kamel S, Refaat T. 2015. Cancer active targeting by nanoparticles: a comprehensive review of literature. J Cancer Res Clin Oncol. 141(5):769–784. doi:10.1007/s00432-014-1767-3.
- Chehelgerdi M, Chehelgerdi M, Allela OQB, Pecho RDC, Jayasankar N, Rao DP, Thamaraikani T, Vasanthan M, Viktor P, Lakshmaiya N, et al. 2023. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Mol Cancer. 22(1):169. doi:10.1186/s12943-023-01865-0.
- Drabczyk A, Kudłacik-Kramarczyk S, Jamroży M, Krzan M. 2024. Biomaterials in drug delivery: advancements in cancer and diverse therapies-review. Int J Mol Sci. 25(6):3126. doi:10.3390/ijms25063126.
- Hartshorn CM, Bradbury MS, Lanza GM, Nel AE, Rao J, Wang AZ, Wiesner UB, Yang L, Grodzinski P. 2018. Nanotechnology strategies to advance outcomes in clinical cancer care. ACS Nano. 12(1):24–43. doi:10.1021/acsnano.7b05108.
- Kandasamy G, Karuppasamy Y, Krishnan UM. 2023. Emerging trends in nano-driven immunotherapy for treatment of cancer. Vaccines (Basel). 11(2):458. doi:10.3390/vaccines11020458.
- Pansri P, Phanthong P, Suthprasertporn N, Kitiyanant Y, Tubsuwan A, Dinnyes A, Kobolak J, Kitiyanant N. 2021. Brain-derived neurotrophic factor increases cell number of neural progenitor cells derived from human induced pluripotent stem cells. Peer J. 9:11388.
- Sell M, Lopes AR, Escudeiro M, Esteves B, Monteiro AR, Trindade T, Cruz-Lopes L. 2023. Application of nanoparticles in cancer treatment: a concise review. Nanomater (Basel). 13(21):2887. doi:10.3390/nano13212887.
- Vedakumari WS, Prabu P, Babu SC, Sastry TP. 2013. Fibrin nanoparticles as possible vehicles for drug delivery. Biochim Biophys Acta. 1830(8):4244–4253. doi:10.1016/j.bbagen.2013.04.032.